FAQs

-What does HB1057 do?

HB1057 protects children under 18 from being subjected to harmful surgeries and procedures that result in permanent sterilization or that expose the children to experimental puberty blockers and cross-sex hormones when used to cause a child to feel or appear as the opposite sex.

-Does Sex Reassignment Surgery Make People Happy?

(…and if we deny the surgery, won’t people commit suicide?)

Find the answer in this short video

-Aren’t these surgeries and hormone injections supported by high-quality research?

No. Much of the research that claims to support these actions is “low to very low” quality.(1) 

-Why is this bill needed?

Every child deserves a natural childhood—one that allows them to experience puberty and other normal changes that shape who they will become. There is nothing natural or healthy about pumping kids full of puberty blockers and cross-sex hormones or performing sterilizing surgeries on them. Children must be protected from permanent, harmful surgeries and experimental hormone interventions that stop natural development and sterilize them.

-What are the risks and potential harms of puberty blockers?

Some of the risks and potential harms include: low bone density, disfiguring acne, high blood pressure, weight gain, abnormal glucose tolerance, breast cancer, liver disease, thrombosis, and cardiovascular disease. (2)

Additional risks and potential harms include:

For Males: Stunting of penile and testicular growth, Sexual dysfunction, prevention of spermatogenesis, and disruption of normal brain and bone development.

For Females: A menopause-like state, blockade of normal breast development, decreased blood flow to vagina and vulva, sexual dysfunction, thinning of vaginal epithelium, vaginal atrophy, prevention of menses/ovulation, and disruption of normal brain and bone development.

-Is the use of GnRH analogues to block a child’s puberty FDA approved?

No.(3)

-What are the risks and potential harms of cross-sex hormones?

Some of the risks and potential harms of cross-sex hormones include:

Sterilization(4), cardiac disease, high blood pressure, blood clots, strokes, diabetes, and cancers. (5)

-Isn’t the puberty suppression and hormonal intervention reversible?

No. Although steps can be taken to resume development and “restart” puberty, the years of development that were lost cannot necessarily be regained and permanent changes to the body will result.

-Aren’t the surgeries reversible?

No. Although cosmetic surgeries can be performed to re-install structures that resemble the original genitalia or breast tissue, actual reversal is not possible.

-Is it possible to have a female brain in a male body, or vice versa?

No. Sex is not defined by the brain, but by the body’s reproductive class. The brain is comprised of brain cells that have either male or female chromosomes and cannot possibly oversee the development of a body that is the opposite sex. There are two sex chromosomes—two X chromosomes in females or an X and a Y in males—in nearly every cell in our bodies. Even hair follicles and teeth all have either male or female chromosomes that correspond with our biological sex.(6)

-What causes gender dysphoria?

We do not yet have a clear answer to the cause of gender dysphoria.

However, there are multiple contributing factors that have been identified, which include:

Overly-simplistic gender-stereotypes, family dynamics, depression, trauma, abuse, autism spectrum disorder, mis-diagnosed homosexual attraction, social contagion, autogynephilia, transvestic disorder, and others.

-How big is the sex reassignment surgery market?

It will reach nearly 1 billion dollars by 2024.(7)


REFERENCE:

1 – Wylie C. Hembree et al., “Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline,” Journal of Clinical Endocrinology and Metabolism 94 (September 2009): 3132.

2 – Anderson, Ryan. When Harry Became Sally. New York, Encounter Books, 2018. Page 127

3 – Ibid.

4 – Eyler AE, Pang SC, Clark A. LGBT assisted reproduction: current practice and future possibilities. LGBT Health 2014;1(3):151-156

5 – Feldman J, Brown GR, Deutsch MB, et al. Priorities for transgender medicl and healthcare research. Curr Opin Endocrinal Diabetes Obes 2016;23:180-187

6 – Parent Resource Guide, Published by Minesota Family Council, 2019. Page 11.

7 – Madeleine Kearns, Sex Reassignment Market to Exceed $968 Million by 2024, National Review, December 6, 2019.